Keyphrases
Randomized Trial
100%
Percutaneous Coronary Intervention
100%
P2Y12 Inhibitors
100%
Dual Antiplatelet Therapy
100%
Confidence Interval
42%
Hazard Ratio
42%
Bleeding
28%
Myocardial Infarction
28%
Bleeding Risk
28%
Bleeding Academic Research Consortium
28%
Cardiovascular Mortality
14%
Efficacy Outcomes
14%
Random Effects Model
14%
Embase
14%
Effective Strategies
14%
All-cause Mortality
14%
PubMed
14%
Massive Bleeding
14%
Stent Thrombosis
14%
Post-percutaneous Coronary Intervention
14%
Major Bleeding
14%
Cardiovascular Outcomes
14%
Bleeding Complications
14%
Primary Safety
14%
Safety Endpoints
14%
Ischemic Risk
14%
Cochrane Central Register of Controlled Trials
14%
Pharmacology, Toxicology and Pharmaceutical Science
Monotherapy
100%
Antiplatelet
100%
Bleeding
50%
Heart Infarction
25%
All Cause Mortality
12%
Stent Thrombosis
12%
Random Effects Model
12%
Cerebrovascular Accident
12%